Centre hospitalier Lyon Sud-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2016

  1. European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

    Haematologica